Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply
N Engl J Med
.
2022 Dec 15;387(24):e65.
doi: 10.1056/NEJMc2212542.
Authors
Carolyn T Bramante
1
,
John B Buse
2
,
David R Boulware
3
Affiliations
1
University of Minnesota Medical School, Minneapolis, MN bramante@umn.edu.
2
University of North Carolina at Chapel Hill, Chapel Hill, NC.
3
University of Minnesota Medical School, Minneapolis, MN.
PMID:
36516100
DOI:
10.1056/NEJMc2212542
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Fluvoxamine
Humans
Ivermectin / therapeutic use
Metformin* / therapeutic use
Substances
Ivermectin
Fluvoxamine
Metformin